Asset
Narazaciclib
Traws Pharma Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04739293 | phase1 | unknown | 2021-05-13 | 2024-10-01 | Traws Pharma, Inc. | Study of ON 123300 in Patients With Advanced Cancer |
FDA applications (0)
This company has no applications containing this asset.